“MuCovid-21” study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic

Background Mucormycosis has been reported in several Indian states with the second wave of COVID-19 from January 2021 onwards. This prospective study was conducted with the objective of defining the contribution or association of various known and many suspected factors in the incidence of this disease during the ongoing pandemic.

Central diabetes insipidus unmasked by corticosteroid therapy for cerebral metastases: beware the case with pituitary involvement and hypopituitarism


Patients with intra-cerebral metastases often receive glucocorticoids, particularly in the presence of peri-lesional vasogenic cerebral oedema. We present a case of presumptive lung carcinoma with cerebral metastases where central diabetes insipidus was unmasked after glucocorticoid administration and correction of undiagnosed central hypocortisolism.

Diabetes & endocrinology: something for everyone

This symposium addressed new developments and controversies in diabetes and endocrinology. The practical management of hyperparathyroidism, thyroid nodules, hyperprolactinaemia and diabetes and thyroid disorders in pregnancy were all discussed. In addition to these traditional areas of endocrinology, there was a focus on the role of endocrinology in ‘non-endocrine’ specialties, namely critical care and cardiovascular disease.

Our approach to the diagnosis and treatment of polymyalgia rheumatica and giant cell (temporal) arteritis

We believe there is a strong case for formalised collaborative care between GPs and  rheumatologists in the management of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), which can be difficult conditions to diagnose and manage. Our rapid access diagnostic care pathways allow early referral of patients who appear to have PMR or GCA, before  glucocorticoids are prescribed.